Investigation of Colistin Heteroresistance and Some Factors Affecting Heteroresistance in Carbapenem-Resistant A. baumannii Strains
Journal Title: Mediterranean Journal of Infection, Microbes and Antimicrobials - Year 2017, Vol 6, Issue 1
Abstract
Introduction: Colistin can be used in patients infected with carbapenem-resistant Acinetobacter baumannii complex (CR-ABC), but recently resistance to colistin and heteroresistance have been reported. In this study we aimed to investigate the colistin heteroresistance rates and the effects of colistin and its combinations on colistin heteroresistance/resistance development in CR-ABC strains in our hospital. Materials and Methods: Heteroresistance analysis was performed on CR-ABC isolates and standard ABC strain [American Type Culture Collection (ATCC) 19606)] strain. To investigate hidden heteroresistance, the isolates were exposed to colistin at sub-inhibitory concentrations. ‘Time-kill’ study was performed on the standard strain and a clinical strain for colistin. Serial passage test was performed to investigate the effects of drug combinations on heteroresistance/resistance development. Results: In the first heteroresistance analysis test, all strains were found to be non-heteroresistant. However, after sub-inhibitory exposure to colistin, colistin heteroresistance/resistance developed in all isolates. In serial passages, colistin-rifampicin and colistin-tigecycline (Col+Tig) combinations were found to be effective and prevented growth of colistin-resistant sub-populations even at sub-inhibitory doses. Colistin-gentamicin (Col+Gen) combination was not found to be effective against the clinical isolate while it was effective on ATCC strain. Colistin-fluconazole combination was found to be ineffective at all concentrations. Conclusion: In our study, it was shown that the strains which were detected to be non-heteroresistant could easily transform to heteroresistant/resistant forms after exposure to colistin. Colistin-rifampicin and Col+Tig combinations were found to be effective and prevented the emergence of heteroresistance/resistance to colistin even at low concentrations. At low concentrations, Col+Gen combination was ineffective against the clinical ABC isolate. Colistin-fluconazole combination failed to inhibit the emergence of resistant bacteria. Heteroresistance or resistance to colistin may easily develop because of inappropriate use of this antibiotic. To prevent this condition, colistin should be administrated at appropriate doses and in combination with the suggested antibiotics.
Authors and Affiliations
Deniz GAZEL, Müşerref TATMAN OTKUN
Keywords
Related Articles
- EP ID EP689346
- DOI 10.4274/mjima.2017.1
- Views 136
- Downloads 0
Are Blood Cultures Useful in Patients with Skin and Soft Tissue Infections?
Introduction: Blood cultures are almost routinely performed in patients hospitalized with skin and soft tissue infections (SSTIs). The aim of this study was to evaluate the diagnostic importance of blood cultures in pati...
Frequency of Hepatitis B Virus Screening in Patients with Systemic Lupus Erythematosus
Introduction: Immunosuppressive drug use is common in the treatment of systemic lupus erythematosus (SLE). In cases receiving immunosuppressive therapy, screening for hepatitis B reactivation risk is also recommended. In...
Retrospective Evaluation of Vancomycin-resistant Enterococci Outbreak in Neonatal Intensive Care Unit
Introduction: Vancomycin-resistance in enterococci (VRE) poses a major threat in hospitals. It is well known that patients in the neonatal intensive care unit (NICU) is especially at risk of nosocomial VRE acquisition. I...
Biofilm-Related Infection: Diagnosis, Treatment, and Prevention
Biofilms can cause infections associated with orthopedic devices, endotracheal tubes, intravenous catheters, urinary catheters, and tissue fillers as well as chronic wound infections, and chronic lung infections in cysti...
Acute Cervical Myelitis as a Rare Complication of Pneumococcal Meningitis in Adults
No Abstract